PSC-induced Galectin-1 Promotes the Malignant Behavior of Pancreatic Ductal Adenocarcinoma
Dong Tang,Qi Wu,Hong Peng Zhang,Zhong Xu Yuan,Jia Ming Xu,Han Jian Zhu,Jin Gao,Zhuang,Zhu Jiang Dai,Xiao Ming Sun,Meng Yue Xu,Hui Wen Fang,Zhen Li,Chao Biao Lin,Chun Feng Shi,Dao Rong Wang
DOI: https://doi.org/10.34175/jno201903004
2019-01-01
journal of nutritional oncology
Abstract:Background Galectin-1 is a β-galactoside-binding protein overexpressed in the pancreatic stellate cells(PSCs) of pancreatic ductal adenocarcinoma(PDAC), while its expression is typically low in pancreatic cancer cells(PCCs). The point at which galectin-1 expression in PCCs increases, and its association with PDAC progression, have been unclear. Methods Galectin-1 expression in PDAC and metastatic lymph nodes was investigated using an immunohistochemical assay. PANC-1 PCC cells were co-cultured with PSCs expressing different levels of galectin-1. Subsequently, galectin-1 was overexpressed in PANC-1 cells using recombinant lentiviruses, and their proliferation, invasion, anchorage-independent growth, and in vivo tumorigenicity were evaluated. Results There was intermediate galectin-1 expression in PCCs, and it was positively associated with galectin-1 expression in PSCs in the PDAC tissues. Galectin-1 was strongly expressed in the metastatic lymph nodes. In the co-culture, high galectin-1 expression in the PSCs increased the galectin-1 expression in the PANC-1 cells. The galectin-1 overexpression in the PANC-1 cells enhanced their clone formation ability, proliferation, and invasion, increased the expression of proliferating cell nuclear antigen(PCNA) and BCL-2, and decreased Bax expression, promoting the establishment and growth of tumors. Conclusion High galectin-1 expression in PSCs induces galectin-1 expression in PCCs and subsequently promotes the malignant biological behavior of PDAC.